BamSEC and AlphaSense Join Forces
Learn More

OraSure Technologies Inc. – Plans of Reorganization, Merger, Acquisition or Similar

Formerly NASDAQ: OSUR
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2
from DFAN14A 4 pages December 17, 2025 via Email Mr. John P. Kenny Chairman of the Board OraSure Technologies, Inc. 150 Webster St. Bethlehem, Pa 18015 Price Performance Graph: OraSure vs. Relevant Indices1 1 Performance Is Calculated for the Period 12/01/20 – 12/12/25. Data for the Bloomberg US 3000 Life Science & Diagnostics Price Return Index, S&P Health Care Index, NASDAQ Composite Index and the NYSE Composite Index Assume Reinvestment of Dividends
12/34/56
EX-2.1
from 10-K 78 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and the Registrant Customarily and Actually Treats as Private and Confidential. Agreement and Plan of Merger by and Among OraSure Technologies, Inc., Project Watson Merger Sub, Inc., Sherlock Biosciences, Inc. and Mr. Paul Meister, as the Securityholder Representative December 19, 2024
12/34/56
EX-2.1
from 8-K 54 pages Asset Purchase Agreement by and Among Orasure Technologies, Inc. (As Seller) and Cryoconcepts, LP (As Buyer) Dated as of August 15, 2019
12/34/56
EX-2.2
from 8-K 38 pages Offer to Purchase for Cash All of the Outstanding Class “A” Common Shares of Dna Genotek Inc. by 7924569 Canada Inc., a Wholly-Owned Subsidiary of Orasure Technologies, Inc
12/34/56
EX-2.1
from 8-K 104 pages Support Agreement Dated July 25, 2011 Among Orasure Technologies, Inc. and 7924569 Canada Inc. and Dna Genotek Inc. and 1548674 Ontario Inc. and the Chaim and Shirley Birnboim Family Trust and Hyman Chaim Birnboim and Roy Birnboim, George Angus, and Naomi Morisawa De Koven
12/34/56
EX-2
from SC 13G ~5 pages Joint Filing Agreement
12/34/56